News & Updates
Filter by Specialty:
Antiseizure drug yields durable seizure frequency reduction, lowers concomitant medication burden
12 Nov 2021
byJairia Dela Cruz
In the treatment of adults with uncontrolled focal seizures, the long-term, open-label use of cenobamate appears to produce high rates of sustained 100-percent and ≥90-percent seizure reduction, with parallel decreases in concomitant antiseizure medication (ASM) doses, according to two separate post hoc analyses of a phase III C021 trial.
Antiseizure drug yields durable seizure frequency reduction, lowers concomitant medication burden
12 Nov 2021Choline, betaine lower risks of cardiovascular events, recurrent stroke
04 Nov 2021
Plasma choline pathway metabolites, including choline and betaine, appear to reduce the risks of cardiovascular events and recurrent stroke, as well as offer incremental value in risk discrimination and stratification in patients with ischaemic stroke, suggests a recent study.